Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer-Reference-Cited by-同舟云学术

Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer

Published:2016-05 Issue: Volume:58 Page:30-37
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Karayama Masato,Inui Naoki,Fujisawa Tomoyuki,Enomoto Noriyuki,Nakamura Yutaro,Kuroishi Shigeki,Yokomura Koshi,Koshimizu Naoki,Sato Masaki,Toyoshima Mikio,Shirai Toshihiro,Masuda Masafumi,Yamada Takashi,Imokawa Shiro,Suda Takafumi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. The Global Burden of Cancer 2013;Fitzmaurice;JAMA Oncol,2015

2. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Reck;Ann Oncol,2014

3. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol,2009

4. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer;Hensing;Lung Cancer,2005

5. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer;Fidias;J Clin Oncol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer;Journal of Comparative Effectiveness Research;2023-02

2. Pemetrexed long-term maintenance therapy for advanced severe lung cancer with long-term progression-free survival: a case report;Anti-Cancer Drugs;2022-10-06

3. The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non‐small cell lung cancer: A meta‐analysis of randomized controlled trials;Journal of Clinical Pharmacy and Therapeutics;2021-10-06

4. The Safety and Effectiveness of Bevacizumab in the Treatment of Nonsquamous Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials;BioMed Research International;2021-09-07

5. Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials;Journal of Chemotherapy;2021-07-06